Vanguard Global Advisers’s MBX Biosciences MBX Stock Holding History
Bought
Maintained
Sold
Other funds holding MBX
Vanguard Global Advisers's MBX Position: Q3 2026 in Review
Vanguard Global Advisers reduced its MBX Biosciences (MBX) stake by 3.6% in Q3 2026, selling an estimated $42.3K and leaving 18,293 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1674.
Vanguard Global Advisers first reported a position in MBX in Q1 2026 and has held it in 3 quarters since. 190 funds tracked by Wall St. Rank hold MBX as of Q3 2026.
- Vanguard Global Advisers held 18,293 shares of MBX Biosciences worth $1.07M as of Q3 2026.
- Vanguard Global Advisers sold 676 MBX Biosciences shares in Q3 2026, an estimated $42.3K.
- MBX Biosciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1674 holding.
- Vanguard Global Advisers first reported a position in MBX Biosciences in Q1 2026 and has held it in 3 quarters since.
- 190 funds tracked by Wall St. Rank held MBX Biosciences as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.